Compare ITW & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITW | SNY |
|---|---|---|
| Founded | 1912 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0B | 104.5B |
| IPO Year | 1994 | 2001 |
| Metric | ITW | SNY |
|---|---|---|
| Price | $290.36 | $43.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $263.45 | $58.00 |
| AVG Volume (30 Days) | 1.3M | ★ 3.3M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | 2.42% | ★ 3.47% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.50 | N/A |
| Revenue | ★ $14,768,000,000.00 | N/A |
| Revenue This Year | $4.27 | $3.49 |
| Revenue Next Year | $3.44 | $6.10 |
| P/E Ratio | $52.90 | ★ $6.14 |
| Revenue Growth | ★ 3.17 | N/A |
| 52 Week Low | $238.82 | $40.89 |
| 52 Week High | $303.16 | $52.68 |
| Indicator | ITW | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 50.80 |
| Support Level | $244.24 | $43.32 |
| Resistance Level | $301.87 | $45.22 |
| Average True Range (ATR) | 6.72 | 0.66 |
| MACD | -0.78 | 0.02 |
| Stochastic Oscillator | 42.39 | 50.88 |
Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.